argenx raises $484 million in gross proceeds in a global offering
Regulated information – Inside information November 6, 2019, 10:45 PM EST November 7, 2019, 04:45 AM CET Breda, the Netherlands / Ghent, Belgium – argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of …